ATNM-400

DEVELOPMENT STEP phase-1
SPONSOR MATRIX Actinium Pharmaceuticals [ATNM]
MECHANISM TARGET // UNMAPPED_TARGET

[THERAPEUTIC_PROFILE]

Target Indications

mCRPC

Mechanism Abstract

A small molecule protein degrader

[CLINICAL_TRIALS_REGISTRY]

// NO_ACTIVE_REGISTRY_STUDIES_FOUND (ATNM-400)